Melissa Christiaens

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

Richard Pötter, Kari Tanderup, Maximilian Schmid et al. · The Lancet Oncology · 2021 · 628 citations

Medicine, Oncology, Radiology +16

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 349 citations

Medicine, Oncology, Pharmacotherapy +13

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 161 citations

Medicine, Oncology, Pharmacotherapy +12

SIOPE – Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy

Thankamma Ajithkumar, Gail Horan, Laëtitia Padovani et al. · Radiotherapy and Oncology · 2018 · 104 citations

Medicine, Oncology, Radiation Oncology +14

Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image–Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study

Maximilian Schmid, Jacob Christian Lindegaard, Umesh Mahantshetty et al. · Journal of Clinical Oncology · 2023 · 80 citations · Full text

Medicine, Oncology, Radiation Oncology +17